Ocular Therapeutix Inc
NASDAQ:OCUL
Ocular Therapeutix Inc
NASDAQ:OCUL
Price:
6.855
USD
-22.8%
Market Cap:
$1.5B
Balance Sheet
Balance Sheet Decomposition
Ocular Therapeutix Inc
Ocular Therapeutix Inc
Balance Sheet Decomposition is not available for
Ocular Therapeutix Inc
Ocular Therapeutix Inc
Balance Sheet
Ocular Therapeutix Inc
Ocular Therapeutix Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
24
|
18
|
37
|
31
|
33
|
42
|
54
|
54
|
228
|
164
|
102
|
196
|
392
|
737
|
|
| Cash Equivalents |
24
|
18
|
37
|
31
|
33
|
42
|
54
|
54
|
228
|
164
|
102
|
196
|
392
|
737
|
|
| Short-Term Investments |
0
|
0
|
37
|
74
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
12
|
21
|
21
|
26
|
32
|
31
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
12
|
21
|
21
|
26
|
32
|
31
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
1
|
2
|
2
|
2
|
5
|
5
|
4
|
8
|
13
|
11
|
|
| Total Current Assets |
24
|
18
|
76
|
107
|
70
|
43
|
56
|
60
|
246
|
191
|
130
|
232
|
441
|
782
|
|
| PP&E Net |
1
|
1
|
2
|
3
|
3
|
11
|
10
|
17
|
14
|
12
|
18
|
18
|
15
|
24
|
|
| PP&E Gross |
1
|
1
|
2
|
3
|
3
|
11
|
10
|
17
|
14
|
12
|
18
|
18
|
15
|
24
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
4
|
5
|
8
|
10
|
13
|
15
|
17
|
20
|
24
|
28
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
2
|
7
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
25
N/A
|
19
-25%
|
78
+309%
|
110
+41%
|
75
-32%
|
55
-26%
|
73
+32%
|
79
+8%
|
262
+233%
|
205
-22%
|
149
-27%
|
252
+69%
|
458
+82%
|
808
+76%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
2
|
4
|
3
|
3
|
3
|
5
|
5
|
4
|
4
|
4
|
|
| Accrued Liabilities |
1
|
1
|
3
|
3
|
5
|
4
|
6
|
9
|
16
|
22
|
26
|
30
|
37
|
47
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
2
|
1
|
0
|
2
|
6
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
3
|
6
|
5
|
8
|
13
|
9
|
12
|
27
|
26
|
31
|
35
|
41
|
51
|
|
| Long-Term Debt |
2
|
1
|
14
|
15
|
14
|
13
|
25
|
49
|
41
|
51
|
54
|
75
|
69
|
71
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
3
|
3
|
21
|
118
|
39
|
29
|
51
|
33
|
32
|
|
| Total Liabilities |
6
N/A
|
4
-30%
|
20
+353%
|
21
+6%
|
23
+11%
|
29
+28%
|
37
+27%
|
82
+122%
|
186
+125%
|
117
-37%
|
114
-3%
|
161
+41%
|
143
-11%
|
154
+8%
|
|
| Equity | |||||||||||||||
| Common Stock |
66
|
74
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
48
|
61
|
89
|
129
|
174
|
237
|
297
|
384
|
539
|
546
|
617
|
698
|
891
|
1 157
|
|
| Additional Paid In Capital |
1
|
1
|
148
|
219
|
226
|
263
|
333
|
380
|
615
|
634
|
652
|
789
|
1 206
|
1 811
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
19
N/A
|
15
-22%
|
59
+294%
|
90
+53%
|
52
-42%
|
26
-50%
|
36
+38%
|
4
N/A
|
76
N/A
|
88
+16%
|
35
-60%
|
91
+157%
|
315
+246%
|
654
+107%
|
|
| Total Liabilities & Equity |
25
N/A
|
19
-25%
|
78
+309%
|
110
+41%
|
75
-32%
|
55
-26%
|
73
+32%
|
79
+8%
|
262
+233%
|
205
-22%
|
149
-27%
|
252
+69%
|
458
+82%
|
808
+76%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
21
|
21
|
21
|
25
|
25
|
30
|
42
|
50
|
76
|
77
|
77
|
115
|
158
|
216
|
|
Switch to:
Switch to:
See Also
Discover More
